The β cell-specific autoimmune CD8 T cells were identified to have stem-like features that could continuously seed the pancreas to sustain β cell destruction; therefore, targeting these progenitors might be a novel immunotherapeutic intervention for T1D [63]. This evidence concerns the gene CD8A and type 1 diabetes mellitus.